Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Now, For Aspirin's Next Magic Trick


IN BUSINESS THIS WEEK

NOW, FOR ASPIRIN'S NEXT MAGIC TRICK

Regular use of aspirin may sharply cut the odds of developing colon cancer, according to a study published in the Dec. 5 New England Journal of Medicine. Based on data from 662,400 people tracked by the American Cancer Society from 1982 to 1988, researchers led by Dr. Michael Thun found that those who took aspirin 16 or more times a month for a year had half the risk of developing fatal colon cancer as nonusers.

Two earlier studies also found a reduced risk among frequent users of aspirin or other nonsteroidal anti-inflammatory drugs, but a third found that an aspirin a day actually boosted the odds of colon cancer somewhat.EDITED BY HARRIS COLLINGWOOD


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus